Proteomic modulation in breast tumors after metformin exposure: results from a “window of opportunity” trial

被引:0
作者
K. Kalinsky
T. Zheng
H. Hibshoosh
X. Du
P. Mundi
J. Yang
S. Refice
S. M. Feldman
B. Taback
E. Connolly
K. D. Crew
M. A. Maurer
D. L. Hershman
机构
[1] Columbia University Medical Center,Department of Medicine, College of Physicians and Surgeons
[2] Columbia University,Herbert Irving Comprehensive Cancer Center
[3] Columbia University,Department of Statistics
[4] Columbia University Medical Center,Department of Pathology and Cell Biology, College of Physicians and Surgeons
[5] Columbia University Medical Center,Department of Surgery, College of Physicians and Surgeons
[6] Columbia University Medical Center,Department of Radiation Oncology, College of Physicians and Surgeons
[7] Columbia University,Department of Epidemiology and Biostatistics, Mailman School of Public Health
来源
Clinical and Translational Oncology | 2017年 / 19卷
关键词
Pre-surgical; Metformin; Reverse Phase Protein Array; Immunohistochemistry; Breast Cancer; Cyclin D1;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:180 / 188
页数:8
相关论文
共 232 条
[1]  
Bowker SL(2006)Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin Diabetes Care 29 254-258
[2]  
Majumdar SR(2013)Clinical pathological characteristics and prognostic analysis of 1013 breast cancer patients with diabetes Breast Cancer Res Treat 137 807-816
[3]  
Veugelers P(2009)Metformin induces unique biological and molecular responses in triple negative breast cancer cells Cell Cycle 8 2031-2040
[4]  
Johnson JA(2009)Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer J Clin Oncol 27 3297-3302
[5]  
Hou G(2006)Metformin Is an AMP Kinase-Dependent Growth Inhibitor for Breast Cancer Cells Cancer Res 66 10269-10273
[6]  
Zhang S(2011)Metformin represses self-renewal of the human breast carcinoma stem cells via inhibition of estrogen receptor-mediated OCT4 expression PLoS One 6 e28068-977
[7]  
Zhang X(2013)Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth Proc Natl Acad Sci 110 972-7511
[8]  
Wang P(2009)Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission Cancer Res 69 7507-1174
[9]  
Hao X(2001)Role of AMP-activated protein kinase in mechanism of metformin action J Clin Invest. 108 1167-157
[10]  
Zhang J(2014)Presurgical trial of metformin in overweight and obese patients with newly diagnosed breast cancer Cancer Invest 32 150-2600